Why the study?
What is the prevalence of hypertrophic cardiomyopathy in fetuses of mothers with gestational diabetes before initiating treatment?
What is the prevalence of hypertrophic cardiomyopathy in fetuses of mothers with gestational diabetes before initiating treatment?
Hypertrophic cardiomyopathy is highly prevalent (54%) in fetuses of mothers with gestational diabetes even before treatment initiation.
No takes yet. Share an insight, caveat, or question.
May warrant fetal echocardiography screening in untreated GDM; leaves open effects of early treatment on cardiac outcomes.
Simões et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: